Administrative Core
行政核心
基本信息
- 批准号:10704708
- 负责人:
- 金额:$ 24.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-14 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAnimal ExperimentationAnimalsCancer CenterClinicClinicalClinical ManagementClinical TrialsCollaborationsCombined Modality TherapyCommunicationComprehensive Cancer CenterCore FacilityDataDevelopment PlansDocumentationEducationEnrollmentEnsureFeedbackFloridaFundingGenomicsGoalsGrantHumanHuman ResourcesHuman Subject ResearchIndividualInstitutionInvestigationLaboratoriesLeadershipManuscriptsMonitorMulti-Institutional Clinical TrialMulticenter TrialsNational Cancer InstituteOffice of Administrative ManagementOralPerformancePreparationProgress ReportsRadiationResearchResearch PersonnelResourcesScheduleServicesSiteStudy SubjectSystemTimeTrainingTreatment EfficacyUniversitiesWorkWritingexperiencehuman subjectinnovationmeetingsoperationprograms
项目摘要
PROJECT SUMMARY
Administrative Core
The Administrative Core is responsible for the overall leadership, management, and execution of the
ROBIN center, and it will provide overall organizational, administrative, scientific and clinical management. The
Administrative Core will oversee and coordinate all ROBIN program components and centrally monitor and
evaluate their performance. In addition, the Administrative Core will facilitate all interactions with the External
Advisory Board (EAB), the Steering Committee, and the other sites of the national ROBIN program. This
ROBIN center involves 3 institutions (Cleveland Clinic, Emory University, and Case Western Reserve
University), with multiple enrollment sites (Cleveland Clinic system, Cleveland Clinic Florida system, Emory
University system) across 2 NCI-designated Comprehensive Cancer Centers (Case Comprehensive Cancer
Center, Emory Cancer Center), with representation across these institutions as project and core leaders. The
Administrative Core personnel will be led by Drs. Chan, Yu, and Scott, with collaboration from the trial and
project leads. Both Drs. Chan and Yu (ROBIN PIs) have extensive experience in managing multi-institution
clinical trial and laboratory-based research programs. The specific aims for the Administrative Core are as
follows. In Aim 1, the Core will provide all organizational, administrative, educational, and scientific
coordination for the ROBIN center projects and cores by cultivating and promoting the ROBIN team through
innovation and excellence, collaboration, leveraging resources, and providing constructive feedback.
In Aim 2, the Core will provide centralized administrative management for all fiscal aspects of the ROBIN
center, including but not limited to clinical trial execution, accounting of grant funds, progress reports,
communication, meeting scheduling and minutes, and manuscript and grant preparation. In Aim 3, the Core
will evaluate research progress through oral and written documentation, with regular input from the EAB,
Steering Committee, and National Cancer Institute (NCI) leadership to ensure that each project meets its
objectives within the proposed time frame and to facilitate interactions with other ROBIN sites for trans-ROBIN
center projects. In Aim 4, the Core will ensure integration across ROBIN components, including projects and
cores, across all sites, and provide interaction through scientific exchanges, coordination of an annual scientific
retreat, and through training and development plans that will ensure state-of-the-art practices. In Aim 5, the
Core will ensure and monitor best practices for human subjects and animal research for all ROBIN center
projects and cores as well as clinical and data operations, and to ensure adequate human and animal
biospecimens for all projects (with the Translational and Clinical Correlates Core).
项目概要
行政核心
行政核心负责全院的全面领导、管理和执行。
ROBIN中心,它将提供全面的组织、行政、科学和临床管理。这
行政核心将监督和协调所有 ROBIN 计划组成部分,并集中监控和
评估他们的表现。此外,行政核心将促进与外部的所有互动
咨询委员会 (EAB)、指导委员会以及国家 ROBIN 计划的其他场所。这
ROBIN中心涉及3家机构(克利夫兰诊所、埃默里大学、凯斯西储大学)
大学),拥有多个招生地点(克利夫兰诊所系统、克利夫兰诊所佛罗里达系统、埃默里大学
大学系统)横跨 2 个 NCI 指定的综合癌症中心(病例综合癌症中心)
中心、埃默里癌症中心),在这些机构中担任项目和核心领导者。这
行政核心人员将由博士领导。 Chan、Yu 和 Scott 在试验和
项目领导。两位博士。 Chan 和 Yu(ROBIN PI)在管理多机构方面拥有丰富的经验
临床试验和基于实验室的研究计划。行政核心的具体目标如下
接下来。在目标 1 中,核心将提供所有组织、行政、教育和科学
通过培养和提升ROBIN团队来协调ROBIN中心项目和核心
创新和卓越、协作、利用资源并提供建设性反馈。
在目标 2 中,核心将为 ROBIN 的所有财务方面提供集中行政管理
中心,包括但不限于临床试验执行、拨款资金会计、进度报告、
沟通、会议安排和会议记录、手稿和拨款准备。在目标 3 中,核心
将通过口头和书面文件评估研究进展,并定期听取 EAB 的意见,
指导委员会和国家癌症研究所 (NCI) 领导层确保每个项目符合其要求
在建议的时间范围内实现目标,并促进与其他 ROBIN 站点的交互以实现跨 ROBIN
中心项目。在目标 4 中,核心将确保 ROBIN 组件之间的集成,包括项目和
跨所有站点的核心,并通过科学交流、年度科学会议的协调来提供互动
务虚会,并通过培训和发展计划确保最先进的实践。在目标 5 中,
Core 将确保和监控所有 ROBIN 中心的人类受试者和动物研究的最佳实践
项目和核心以及临床和数据操作,并确保足够的人力和动物
所有项目的生物样本(具有转化和临床相关核心)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy An-thy Chan其他文献
Timothy An-thy Chan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy An-thy Chan', 18)}}的其他基金
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
基因组和微环境决定因素、时间动态以及基于放射的联合疗法的治疗效果
- 批准号:
10746700 - 财政年份:2023
- 资助金额:
$ 24.74万 - 项目类别:
Project 3 Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint Blockade
项目 3 辐射和免疫检查点封锁治疗反应的分子机制
- 批准号:
10818969 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
基因组和微环境决定因素、时间动态以及基于放射的联合疗法的治疗效果
- 批准号:
10875876 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
基因组和微环境决定因素、时间动态以及基于放射的联合疗法的治疗效果
- 批准号:
10704661 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
基因组和微环境决定因素、时间动态以及基于放射的联合疗法的治疗效果
- 批准号:
10526300 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
Project 1 Genetic and Immunologic Mechanisms Underlying Combination Sacituzumab plus Radiation Therapy for Bladder Cancer
项目 1 Sacituzumab 联合放射治疗膀胱癌的遗传和免疫机制
- 批准号:
10704713 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
Project 1 Genetic and Immunologic Mechanisms Underlying Combination Sacituzumab plus Radiation Therapy for Bladder Cancer
项目 1 Sacituzumab 联合放射治疗膀胱癌的遗传和免疫机制
- 批准号:
10526303 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
相似国自然基金
早期环境暴露对儿童哮喘免疫保护的动物实验和机制研究
- 批准号:82300031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
羊膜间充质干细胞联合水凝胶支架材料移植干预脊髓损伤动物实验研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
深渊片脚类动物原位代谢测量与高质量实验技术研究
- 批准号:42276191
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
节肢动物病毒多样性的生态驱动因素研究:以新岗山生态系统功能实验基地为例
- 批准号:32200004
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
浮游动物和湍流的相互作用的实验研究
- 批准号:12102165
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Contribution of locus coeruleus activity patterns on tau deposition in Alzheimer's disease
蓝斑活性模式对阿尔茨海默病中 tau 蛋白沉积的贡献
- 批准号:
10646691 - 财政年份:2023
- 资助金额:
$ 24.74万 - 项目类别:
Changes in hippocampal microstructure and hippocampal-dependent memory accompanying hormonal fluctuation in naturally cycling women
自然循环女性荷尔蒙波动引起的海马微观结构和海马依赖性记忆的变化
- 批准号:
10642941 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别: